We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > I-SPY 2

News List

Quantum Leap Healthcare, G1 Therapeutics Announce Trilaciclib Evaluation americanpharmaceuticalreview
January 16, 2020
Quantum Leap Healthcare Collaborative™ and G1 Therapeutics announced a collaboration to evaluate trilaciclib, an investigational therapy designed to improve outcomes for people with cancer treated with chemotherapy, in a new randomized ...
Olaparib, Durvalumab for I-SPY 2 Trial Announces americanpharmaceuticalreview
September 10, 2018
Quantum Leap Healthcare Collaborative (QLHC) announced that a new randomized, investigational treatment arm for the I-SPY 2 TRIAL includes the study of olaparib and durvalumab, two agents from AstraZeneca.